Organization | Forest Laboratories

Forest Laboratories Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4

Founded: New York NY United States (1954)

Status: Acquired by Actavis (2014) → now AbbVie (2019)

Organization Overview

First Clinical Trial

2000

NCT00035477

First Marketed Drug

1954

epinephrine (levophed)

First NDA Approval

2002

escitalopram (lexapro)

Last Known Activity

2018

Timeline

NOW

Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Forest Laboratories | FOREST LABS | FOREST LABS INC | FOREST LABS LLC | FOREST PHARMS | Forest Research Institute, a subdisiary of Forest Laboratories, Inc. | Forest Research Institute, a subsidiary of Forest Laboratories | Forest Research Institute, a subsidiary of Forest Laboratories Inc | Forest Research Institute, a subsidiary of Forest Laboratories Inc. | Forest Research Institute, a subsidiary of Forest Laboratories, Inc. | Forest Research Institute, a Subsidiary of Forest Laboratories Inc. | Forest Research Institute, a Subsidiary of Forest Laboratories, Inc. | Forest Research Institute Inc., A Subsidiary of Forest Laboratories | Forest Research Institute, Inc., a Subsidiary of Forest Laboratories, Inc. | Forest Research Institute Inc., A Subsidiary of Forest Laboratories Inc | Forest Research Institute, Inc.- A Subsidiary of Forest Laboratories, Inc.

Active Ingredients

Marketed Drugs (28)

Key: Forest Laboratories (27) Acquired (1)

acamprosate (campral) (2004)

acetaminophen (tylenol) (1983)

aclidinium (tudorza pressair) (2012 NDA)

amylase (2009)

asenapine (saphris) (2009)

avibactam (Avycaz) (NDA)

cariprazine (vraylar) (2015 NDA)

citalopram (celexa) (1999)

codeine (Phenergan) (1954)

diphenhydramine (benadryl) (1954)

epinephrine (levophed) (1951)

escitalopram (lexapro) (2002 NDA)

hydrocodone (hycodan) (1983)

ibuprofen (motrin) (2004)

levomilnacipran (fetzima) (2013 NDA)

linaclotide (linzess) (2012 NDA)

lipase (2009)

memantine (namenda) (2003 NDA)

milnacipran (savella) (2009 NDA)

nebivolol (bystolic) (NDA)

oxycodone (oxycontin) (2004)

pancrelipase (creon) (2009)

polymyxin b sulfate (poly-rx) (1972)

propiolattone (1959)

rimantadine (flumadine) (1993)

roflumilast (daliresp) (2011 NDA)

theophylline (synophylate) (1985)

urea (1972)

Drugs in Phase 4 Trials (25)

Key: Forest Laboratories (23) Acquired (2)

acamprosate (campral) (8 trials)

angiotensin ii (1 trial)

asenapine (saphris) (4 trials)

carvedilol (coreg) (1 trial)

cefazolin (ancef) (2 trials)

ceftaroline fosamil (teflaro) (28 trials)

ceftriaxone (rocephin) (6 trials)

citalopram (celexa) (4 trials)

escitalopram (lexapro) (37 trials)

hydrochlorothiazide (esidrix) (5 trials)

levofloxacin (levaquin) (7 trials)

levomilnacipran (fetzima) (8 trials)

linaclotide (linzess) (15 trials)

lisinopril (zestril) (1 trial)

memantine (namenda) (43 trials)

metoprolol (lopressor) (17 trials)

milnacipran (savella) (31 trials)

nebivolol (bystolic) (38 trials)

nitroglycerin (transderm-nitro) (2 trials)

pancrelipase (creon) (14 trials)

paroxetine (paxil) (3 trials)

perflutren protein-type a microspheres (Optison) (1 trial)

sertraline (zoloft) (4 trials)

vancomycin (Vancocin) (10 trials)

vilazodone (viibryd) (20 trials)

Drugs in Phase 3 Trials (45)

Key: Forest Laboratories (31) Acquired (14)

adenosine (Adenocard) (2 trials)

apadenoson (5 trials)

aripiprazole (abilify) (1 trial)

avibactam (Avycaz) (9 trials)

azimilide (8 trials)

aztreonam (azactam) (6 trials)

Bismuth Subcitrate Potassium (Pylera) (2 trials)

cariprazine (vraylar) (22 trials)

ceftazidime (fortaz) (7 trials)

cephalexin (keflex) (1 trial)

ciprofloxacin (cipro) (2 trials)

clarithromycin (biaxin) (2 trials)

clavulanate (Augmentin) (1 trial)

clindamycin (cleocin) (1 trial)

Desmoteplase (1 trial)

doripenem (doribax) (3 trials)

duloxetine (Cymbalta) (2 trials)

dutogliptin (8 trials)

eluxadoline (viberzi) (3 trials)

escalitopram (Lexapro) (1 trial)

fluoxetine (prozac) (3 trials)

itropride (8 trials)

Lactobacillus acidophilus (1 trial)

lamivudine (epivir) (1 trial)

linezolid (zyvox) (4 trials)

meropenem (merrem) (2 trials)

mesalamine (rowasa) (1 trial)

metronidazole (flagyl) (4 trials)

neramexane (1 trial)

olanzapine (zyprexa) (1 trial)

omeprazole (prilosec) (3 trials)

procaine benzylpenicillin (novocaine) (2 trials)

quetiapine (seroquel) (1 trial)

roflumilast (daliresp) (2 trials)

sitagliptin (januvia) (3 trials)

sotalol (betapace) (1 trial)

sulfamethoxazole (gantanol) (2 trials)

tetracycline (tetrex) (1 trial)

tobramycin (nebcin) (1 trial)

trimethoprim (2 trials)

ulipristal (ella) (2 trials)

ursodeoxycholic acid (3 trials)

valsartan (diovan) (1 trial)

vitamin e (1 trial)

zidovudine (retrovir) (1 trial)

Drugs in Phase 2 Trials (23)

Key: Forest Laboratories (14) Acquired (9)

Acorafloxacin (2 trials)

atenolol (tenormin) (1 trial)

atorvastatin (lipitor) (1 trial)

cebranopadol (6 trials)

cefepime (maxipeme) (1 trial)

dexloxiglumide (1 trial)

encainide (Enkaid) (1 trial)

esomeprazole (nexium) (1 trial)

eur-1100 (1 trial)

flecainide (tambocor) (1 trial)

imipramine (tofranil) (1 trial)

moricizine (ethmozine) (1 trial)

moxifloxacin (avelox) (3 trials)

oglemilast (3 trials)

piperacillin (pipracil) (1 trial)

porfimer (photofrin) (1 trial)

ppd10558 (1 trial)

pregabalin (lyrica) (2 trials)

radiprodil (1 trial)

risperidone (risperdal) (2 trials)

tapentadol (nucynta) (1 trial)

tazobactam (Zosyn) (1 trial)

venlafaxine (effexor) (1 trial)

Drugs in Phase 1 Trials (2)

Key: Forest Laboratories (1) Acquired (1)

eur-1066 (1 trial)

ondansetron (zofran) (3 trials)

Drugs in Other Trials (1)

sildenafil (viagra) (1 trial)

Indications

Approved Indications

Alzheimer Disease

Anxiety Disorders

Bipolar Disorder

Bronchial Spasm

Bronchitis, Chronic

Depressive Disorder, Major

Intraabdominal Infections

Irritable Bowel Syndrome

Pulmonary Disease, Chronic Obstructive

Urinary Tract Infections

Experimental Indications (Clinical Trials, Phases 1-4)

Alcoholism (Phase 4)

Alzheimer Disease (Phase 4)

Amyotrophic Lateral Sclerosis (Phase 2)

Angina Pectoris (Phase 4)

Anxiety Disorders (Phase 4)

Anxiety, Separation (Phase 4)

Aphasia, Primary Progressive (Phase 4)

Arrhythmias, Cardiac (Phase 3)

Arthritis (Phase 4)

Arthritis, Infectious (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Asperger Syndrome (Phase 4)

Asthma (Phase 4)

Asthma, Exercise-Induced (Phase 2)

Atrial Fibrillation (Phase 3)

Autism Spectrum Disorder (Phase 4)

Autistic Disorder (Phase 4)

Back Pain (Phase 3)

Bacteremia (Phase 4)

Bacterial Infections (Phase 3)

Behavior, Addictive (Phase 4)

Binge-Eating Disorder (Phase 4)

Bipolar Disorder (Phase 4)

Brain Injuries (Phase 4)

Brain Injuries, Traumatic (Phase 4)

Bulimia (Phase 4)

Cardiovascular Diseases (Phase 3)

Cellulitis (Phase 4)

Child Development Disorders, Pervasive (Phase 2)

Chronic Pain (Phase 4)

Cognition Disorders (Phase 3)

Cognitive Dysfunction (Phase 4)

Communicable Diseases (Phase 4)

Compulsive Personality Disorder (Phase 4)

Constipation (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Cystic Fibrosis (Phase 4)

Delirium (Phase 4)

Dementia (Phase 4)

Depression (Phase 4)

Depression, Postpartum (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Developmental Disabilities (Phase 2)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Neuropathies (Phase 2)

Diarrhea (Phase 3)

Disease (Phase 4)

Disruptive, Impulse Control, and Conduct Disorders (Phase 4)

Down Syndrome (Phase 4)

Dyspepsia (Phase 3)

Dyssomnias (Phase 4)

Dysthymic Disorder (Phase 4)

Emergencies (Phase 3)

Eosinophilic Esophagitis (Phase 2)

Epilepsy (Phase 4)

Epilepsy, Temporal Lobe (Phase 4)

Erectile Dysfunction (Phase 4)

Esophagitis (Phase 2)

Essential Tremor (Phase 4)

Exocrine Pancreatic Insufficiency (Phase 4)

Facial Pain (Phase 4)

Facies (Phase 4)

Fatigue (Phase 4)

Febrile Neutropenia (Phase 2)

Feeding and Eating Disorders (Phase 4)

Fever (Phase 2)

Fibromyalgia (Phase 4)

Fibrosis (Phase 4)

Fissure in Ano (Phase 4)

Fractures, Bone (Phase 4)

Fractures, Open (Phase 4)

Frontotemporal Dementia (Phase 4)

Frontotemporal Lobar Degeneration (Phase 4)

Gambling (Phase 4)

Gastroparesis (Phase 2)

Glucose Intolerance (Phase 4)

Heartburn (Phase 3)

Heart Diseases (Phase 3)

Heart Failure (Phase 2)

Helicobacter Infections (Phase 3)

Hemorrhage (Phase 3)

Huntington Disease (Phase 4)

Hyperalgesia (Phase 1)

Hypertension (Phase 4)

Hypertension, Portal (Phase 2)

Infections (Phase 4)

Intraabdominal Infections (Phase 3)

Irritable Bowel Syndrome (Phase 4)

Joint Diseases (Phase 4)

Leiomyoma (Phase 3)

Low Back Pain (Phase 2)

Lung Diseases (Phase 2)

Lung Diseases, Obstructive (Phase 2)

Lupus Erythematosus, Systemic (Phase 4)

Memory Disorders (Phase 2)

Mental Disorders (Phase 2)

Motor Neuron Disease (Phase 2)

Multiple Sclerosis (Phase 4)

Myocardial Ischemia (Phase 4)

Myofascial Pain Syndromes (Phase 4)

Myofibroma (Phase 3)

Nausea (Phase 1)

Neuralgia (Phase 2)

Neutropenia (Phase 2)

Night Eating Syndrome (Phase 3)

Obsessive-Compulsive Disorder (Phase 4)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Osteomyelitis (Phase 4)

Pain, Postoperative (Phase 4)

Pancreatitis (Phase 3)

Pancreatitis, Chronic (Phase 3)

Parasomnias (Phase 4)

Parkinson Disease (Phase 4)

Peripheral Arterial Disease (Phase 3)

Peripheral Vascular Diseases (Phase 3)

Phobic Disorders (Phase 3)

Pick Disease of the Brain (Phase 4)

Pneumonia (Phase 4)

Pneumonia, Bacterial (Phase 4)

Polyneuropathies (Phase 2)

Prehypertension (Phase 4)

Premenstrual Syndrome (Phase 4)

Problem Behavior (Phase 2)

Psychomotor Agitation (Phase 4)

Psychotic Disorders (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Pyelonephritis (Phase 3)

Recurrence (Phase 4)

Renal Insufficiency (Phase 3)

Schizophrenia (Phase 4)

Sclerosis (Phase 4)

Sepsis (Phase 1)

Shoulder Pain (Phase 4)

Sinusitis (Phase 4)

Skin Diseases (Phase 4)

Skin Diseases, Bacterial (Phase 2)

Skin Diseases, Infectious (Phase 4)

Sleep Wake Disorders (Phase 4)

Soft Tissue Infections (Phase 3)

Somatoform Disorders (Phase 4)

Spinal Diseases (Phase 4)

Staphylococcal Infections (Phase 4)

Staphylococcal Skin Infections (Phase 4)

Steatorrhea (Phase 4)

Stress Disorders, Post-Traumatic (Phase 4)

Stress Disorders, Traumatic (Phase 4)

Stroke (Phase 3)

Surgical Wound Infection (Phase 4)

Syndrome (Phase 4)

Systemic Inflammatory Response Syndrome (Phase 1)

Tremor (Phase 4)

Urinary Tract Infections (Phase 3)

Uterine Hemorrhage (Phase 3)

Ventricular Dysfunction, Left (Phase 4)

Vulvar Vestibulitis (Phase 3)

Vulvodynia (Phase 3)

Wounds and Injuries (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 349
# of Trial APIs: 96